Body composition and serum prostate-specific antigen: Review and findings from Flint Men's Health Study

被引：27

作者：

Beebe-Dimmer, Jennifer L.

Faerber, Gary J.

Morgenstern, Hal

Werny, David

Wojno, Kirk

Halstead-Nussloch, Bronwen

Cooney, Kathleen A.

机构：

[1] Wayne State Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA

[2] Wayne State Sch Med, Dept Internal Med, Detroit, MI 48201 USA

[3] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA

[4] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA

[5] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA

来源：

UROLOGY | 2008年 / 71卷 / 04期

关键词：

D O I：

10.1016/j.urology.2007.11.049

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies have suggested that obesity is associated with lower serum prostate-specific antigen levels, perhaps influencing the recommendation for prostate biopsy and potentially explaining part of the observed poorer prognosis among obese men. African-American men have the greatest rates of prostate cancer and are more likely to die of the disease, making early detection a priority in this group. We present findings from the Flint Men's Health Study, a study of African-American men, that are consistent with Most Studies Suggesting that overweight men have prostate-specific antigen levels that are 0.15 to 0.30 n-/mL lower than those who are not overweight. We have coupled our results with a systematic review Of publications in this area.

引用

收藏

页码：554 / 560

页数：7

相关论文

共 43 条

[31] Association between insulin-like growth factor-I:insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women [J].

Sandhu, MS ;

Gibson, JM ;

Heald, AH ;

Dunger, DB ;

Wareham, NJ .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (01) :166-170

[32] Advances in cancer epidemiology: Understanding causal mechanisms and the evidence for implementing interventions [J].

Schottenfeld, D ;

Beebe-Dimmer, JL .

ANNUAL REVIEW OF PUBLIC HEALTH, 2005, 26 :37-60

[33] Prostate cancer screening practices and cancer control research (United States) [J].

Schottenfeld, D ;

Colditz, GA .

CANCER CAUSES & CONTROL, 2002, 13 (01) :1-5

[34] Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men [J].

Smith, DS ;

Carvalhal, GF ;

Mager, DE ;

Bullock, AD ;

Catalona, WJ .

JOURNAL OF UROLOGY, 1998, 160 (05) :1734-1738

[35] PROSTATE-SPECIFIC ANTIGEN AS A SERUM MARKER FOR ADENOCARCINOMA OF THE PROSTATE [J].

STAMEY, TA ;

YANG, N ;

HAY, AR ;

MCNEAL, JE ;

FREIHA, FS ;

REDWINE, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) :909-916

[36] The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? [J].

Stamey, TA ;

Caldwell, M ;

McNeal, JE ;

Nolley, R ;

Hemenez, M ;

Downs, J .

JOURNAL OF UROLOGY, 2004, 172 (04) :1297-1301

[37] Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy [J].

Strom, SS ;

Wang, XM ;

Pettaway, CA ;

Logothetis, C ;

Yamamura, Y ;

Do, KA ;

Babaian, RJ ;

Troncoso, P .

CLINICAL CANCER RESEARCH, 2005, 11 (19) :6889-6894

[38] Prostate cancer and prostate-specific antigen: The more we know, the less we understand [J].

Thompson, I ;

Leach, RJ ;

Pollock, BH ;

Naylor, SL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14) :1027-1028

[39] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].

Thompson, IM ;

Pauler, DK ;

Goodman, PJ ;

Tangen, CM ;

Lucia, MS ;

Parnes, HL ;

Minasian, LM ;

Ford, LG ;

Lippman, SM ;

Crawford, ED ;

Crowley, JJ ;

Coltman, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246

[40] Relationship of body mass index and prostate specific antigen in a population-based study [J].

Thompson, IM ;

Leach, R ;

Troyer, D ;

Pollock, B ;

Naylor, S ;

Higgins, B .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (02) :127-131

← 1 2 3 4 5 →